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The study aims to assess the feasibility of using a computer assisted diagnostic interview by 
GPs and to examine the level of agreement between the Spanish version GMHAT/PC 
diagnosis and psychiatrists' ICD-10 based clinical diagnosis. 
Participants in the study ranged from those who were in remission to others who had 
different mental illnesses. They were recruited from inpatient and outpatient mental health 
settings. All consecutive patients were interviewed using Spanish version of GMHAT/PC 
and  they were assessed independently by psychiatrists to in order to get their ICD-10 based 
diagnosis. 
Two hundred ninety-nine patients participated in the study. The mean duration of interview 
was 12.5 minutes. There is an acceptable to good level of agreement between the GP’s 
(GMHAT/PC) diagnoses and the psychiatrists’ (clinical) diagnoses of any mental illness, 
Kappa 0.58 95% C.I (0.46, 0.72). There is good level of sensitivity (81%) and specificity 
(92%), with GPs correctly identifying 242 out of the 250 participants diagnosed with 
mental illness and 27 out of 35 of those without. 
The finding of the study suggest that GMHAT/PC Spanish version used by GPs detected 
mental disorders accurately and it was feasible to use GMHAT/PC (Spanish version) in 







The model of providing services for mental illness through primary health care has been 
recognized by the health authorities of different countries as well as the WHO. In Latin 
America, the vast majority of people with mental health problems have their initial contact 
with primary care physicians. Therefore, it is important to establish systems to help doctors 
in identifying people with mental health problems at the earliest opportunity and provide 
appropriate interventions. The GMHAT/PC appears promising for this purpose showing 
adequate levels of sensitivity and specificity in different countries where it has been 
evaluated (please insert references).  
Some people may argue that every country has to create its own assessment methods or 
instruments taking account of cultural and language differences.  Measures of 
psychopathological symptoms leading to a diagnosis have been especially criticised for 
their universal application (Bhui, Mohamud, Warfa, Craig, & Stansfeld, 2003). They resist 
using other internationally accepted tools for that reason.  However all cross-cultural 
studies using internationally accepted diagnostic methods such as SCAN, CIDI or MINI 
found that these diagnostic tools accurately detect mental illness in all cultures (Dy & 
Lecrubier, 1995; Kohn et al., 2005; Pull et al., 1997).  There may be variations in 
prevalence of mental disorders in different countries. In a transcultural study carried out by 
the WHO in the primary care attenders of 14 different countries using the same diagnostic 
criteria by applying the CIDI (Dy & Lecrubier, 1995) found that the overall prevalence rate 
of mental illness meeting ICD-10 criteria was 24%. It however ranged from a high of 
52.5% in Santiago de Chile to a low 7.3% in Shanghai (Dy & Lecrubier, 1995).  
An international instrument taking account of cultural and language sensitivities, following 
a properly carried out validation in that culture,  could easily be used in the respective 
country (Sanchez & Echeverry, 2004). To create a new tool is time consuming and 
expensive. That has to go through the same rigorous validation process in any case. It is 
therefore sensible to translate, adapt and validate an existing international tool, especially in 
low to middle income countries. The added advantage is that using the same tools gives 
useful data and information for cross-cultural and international comparisons. International 
data based on studies using the instrument also help in establishing the robustness of its 
psychometric properties.  
Computer-assisted semi-structured clinical interview tools such as GMHAT/PC are not 
validated in Colombia so far. Most tools that are used so far have some validity and most of 
them are paper based rating scales or interview schedules that had been used for research 
studies. GMHAT/PC on the other hand is primarily developed for clinical use. It has 
facility to describe the problems reported by patient, as well as recording and rating 
symptoms using practitioner’s clinical judgement based on all the information available to 
him. The process of clinical assessment using GMHAT/PC is therefore very close to what 
is ideally expected of primary care health worker. The added advantage of getting the 
output in a document form with descriptive details, measurement of symptom groups and 
all diagnostic possibilities makes it some way ahead of all other tools available so far.  
 It is therefore useful to translate adapt and validate GMHAT/PC to assist in providing 
ICD-10 based diagnosis in day to day practice in primary care and general health setting. 
The researcher and the author of this thesis (PT) had an opportunity to participate in the 
development of Spanish version of GMHAT/PC right from the outset. The author has 
therefore taken account of adapting GMHAT/PC to meet the needs of Spanish speaking 
countries specially that of Colombia. The results of this study will therefore be useful to 
plan and improve clinical care of people with mental disorders in primary care settings as 
well as to plan public health interventions. 
  
The study aims to assess the feasibility of using a computer assisted diagnostic interview by 
GPs and to examine the level of agreement between the Spanish version GMHAT/PC 
diagnosis and psychiatrists' ICD-10 based clinical diagnosis. 
Methods: 
First, it was necessary to establish a proper and clinically relevant Spanish translation of the 
GMHAT/PC. The English version was translated into Spanish by a clinician who was 
fluent in both languages. The translated version was then reviewed in a meeting with a 
member of the GMHAT team, the principal investigator and an experienced Spanish 
psychiatrist working in England. In that meetings the GMHAT/PC Spanish questions were 
constructed in the way that they were easily understood by patients both in Latin America 
Spanish speaking countries as well as in Spain. This was important to overcome country 
specific differences as we found that some questions needed major revision. It was 
necessary to retain and adjust some phrases so that Spanish GMHAT/PC can easily be used 
in Colombia as well as in Spain. The team compared the back translation (from Spanish to 
English) with the original GMHAT/PC questions and made some further necessary 
alterations to make the final version.  
The validation study included participants ranging from those who were in remission to 
having symptoms of severe mental illness. They were recruited from inpatient and 
outpatient mental health settings. Those in the mental health setting were expected to have 
a wide range of psychiatric diagnoses (anxiety disorders, depression, psychosis, bipolar 
affective disorder, organic mental disorders, and other diagnosis). The study aimed to have 
approximately 50 patients with each of these diagnoses to form a sample of around 300 
patients.   
 Patients were interviewed by GPs using GMHAT / PC. They had a full training prior to 
carrying out study interviews.  All Patients (participants) were interviewed independently 
by psychiatrists with a good deal of clinical experience who were unaware of the 
GMHAT/PC diagnoses. They made ICD-10 based clinical diagnosis. The GMHAT/PC 
diagnosis and the psychiatrists’ ICD-10 based clinical diagnosis were compared to examine 
the agreement. 
GMHAT/PC: 
The GMHAT/PC is a computerized clinical assessment tool developed to assess and 
identify mental health problems in primary care.  
The first screen is for patient information and administration of the program. The 
introductory screens facilitate inputting of descriptive information in the following fields: 
presenting symptoms, and relevant past, family, and personal problems.  
The following screens consist of a series of questions leading to a comprehensive yet quick 
mental state assessment focusing sequentially on the following symptoms or problems: 
worries; anxiety and panic attacks; concentration; depressed mood, including suicidal risk; 
sleep; appetite; eating disorders; hypochondriasis; obsessions and compulsions; phobia; 
mania/hypomania;  thought disorder; psychotic symptoms(delusions and hallucinations); 
disorientation; memory impairment; alcohol misuse; drug misuse; personality problems; 
stressors. One question at a time appears from these respective subsections. The questions 
proceed in clinical order along a tree-branch structure. For each of the major clinical 
disorders there are one or two screening questions. The interview moves on to the next 
subsection, if the patient does not have symptoms based on the screening items of a 
subsection. 
At the end of the interview the screen asks to put the interviewer’s details and the clinical 
diagnosis. The screen then proceeds to a menu showing the following items: a) rating 
scores and computer diagnosis; b) Assessment and c) referral letter.  
The main symptom groups on which the rating scores are based are anxiety, depression, 
concentration, eating disorder, hypochondriasis, phobias, obsessions, mania, psychosis, 
memory impairment and disorientation. In addition, there are sections for alcohol and other 
drug misuse, stressful events and personality difficulties.  
The main computer diagnosis is derived using a hierarchical model and designed around 
ICD-10. The diagnostic program takes account of severity of symptoms (moderate to 
severe). It also generates alternative diagnosis based on presence of symptoms of other 
disorders. 
Various studies have been dedicated to assess the psychometric properties of the tool 
showing results allow recommending its use in different populations. The GMHAT/PC has 
been proven to be useful to make accurate diagnosis in different settings and with different 
professions(Sharma VK, 2013). GMHAT/PC-based diagnoses showed consistently good 
agreement with International Classiﬁcation of Diseases, 10th Revision (ICD-10)-based 
clinical diagnoses made by psychiatrists in various studies (B. B. Sharma et al., 2013). It 
also shows reliability and validity among different psychiatrists using HADS scores as a 
comparator (V. K. Sharma et al., 2010). 
Results: 
Two hundred ninety-nine patients participated in the study, 162 (54.18%) males and 137 
(45.81%) females in the age range of 14-78 (median 36.03, Standard Deviation 14.16). The 
interviews were carried out at three sites, 55 (18.39%) were outpatients and 244 (81.6%) 
inpatients. All patients were interviewed independently by seven psychiatrists with a good 
deal of clinical experience. 
The overall mean time taken to administer GMHAT was 12.5 min, Standard Deviation 9.98 
(range 3-36 min). 
 
Inter-rater reliability: 
In this study, the inter-rater reliability was established by ratings of video recorded 
interviews. Two psychiatrists’ ratings were taken as the gold standard.  The prospective 
GMHAT/PC interviewers (GPs) rated the video-recorded interviews and their ratings were 
compared with that of psychiatrist (gold standard) to check the inter-rater reliability. 
Validity: 
The study takes account of all diagnosis made by psychiatrists as well as GMHAT/PC. 
Psychiatrists made a single diagnosis in 183 (61%) cases, multiple (two) diagnosis in 112 
(37%) cases and multiple (three) diagnosis in another four cases. GMHAT/PC in almost all 
cases gave additional multiple diagnoses.  
There is an acceptable to good level of agreement between the GP’s (GMHAT/PC) 
diagnoses and the psychiatrists’ (clinical) diagnoses of any mental illness, Kappa 0.58;  
95% C.I (0.46, 0.72). There is good level of sensitivity (81%) and specificity (92%), with 
GPs correctly identifying 242 out of the 250 participants diagnosed with mental illness and 
27 out of 35 of those without. 
The concordance of psychiatrists’ ICD-10 based clinical diagnoses and GMHAT/PC 
diagnoses is given in table 1. 
Table 1. Level of agreement (Kappa) between psychiatrists’ diagnoses and GMHAT/PC 
diagnoses 
Diagnosis Psychiatrists (n) GMHAT/PC (n) Kappa IC 95% 
Any diagnosis 264 250 0.58 (0.46, 0.72) 
Psychotic 
disorder 
117 129 0.56 (0.46, 0.66) 
Organic 
disorder 
8 8 0.87 (0.69, 1.00) 
Alcohol and 
drug abuse 
64 59 0.62 (0.50, 0.74) 
Depression 38 68 0.53 (0.41, 0.65) 
No mental 
illness 
35 49 0.58 (0.46, 0.72) 
Anxiety 10 93 0.14 (0.06, 0.22) 
Bipolar disorder 
(mania) 
59 50 0.60 (0.49, 0.73) 
Learning 
disability 
50 33 0.40 (0.26, 0.55) 
Personality 
disorder 
30 28 0.39 (0.22, 0.56) 
 
Concordance was considered as excellent if kappa was greater than 0.75; acceptable to 
good with values between 0.4 and 0.74, and poor when it was less than 0.4. 
Anxiety Disorders 
The level of agreement for the diagnosis of anxiety disorders was slight: Kappa 0.14, 95% 
C.I (0.06, 0.22). Sensitivity was 100% with GPs correctly identifying 10 of the 10 
participants diagnosed with anxiety disorders. The specificity was 71% with the GP 
correctly identifying 206 of the 289 participants not suffering from anxiety disorders. 
Depression 
The level of agreement for depression was acceptable to good (Kappa 0.53, 95% C.I. 0.41, 
0.65). Sensitivity (84%) and specificity (86%) with the GPs correctly identifying 32 of the 
38 participants diagnosed by the psychiatrists as suffering from depression and 225 out of 
261 of those without. 
Psychosis 
The level of agreement for the diagnosis of psychosis was acceptable to good: Kappa 0.56, 
95% C.I (0.46, 0.66). Sensitivity was 78% with GPs correctly identifying 91 of the 117 
participants diagnosed with psychosis. The specificity was 79% with the interns correctly 
identifying 144 of the 182 participants not suffering from psychosis. 
Mania 
The level of agreement for bipolar affective disorder (mania) was acceptable to good 
(Kappa 0.60, 95% C.I. 0.49, 0.73). Sensitivity (63%) and specificity (95%) with the GPs 
correctly identifying 37 of the 59 participants diagnosed by the psychiatrists as suffering 
from bipolar affective disorder and 227 out of 240 of those without. 
Organic Disorders 
The level of agreement for the diagnosis of organic mental disorder was excellent: Kappa 
0.87, 95% C.I (0.69, 1.00). Sensitivity was 88% with interns correctly identifying 7 of the 8 
participants diagnosed with organic mental disorders. The specificity was 100% with the 
GPs correctly identifying 290 of the 291 participants not suffering from organic mental 
disorder. 
The sensitivity, specificity, positive predicted value and negative predicted value of each 
diagnosis is given in table 11. 
Table 2. Sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) of each diagnosis. 
Diagnosis Sensitivity Specificity PPV NPV 
Psychotic disorder 78% 79% 71% 85% 
Organic disorder 88% 100% 88% 100% 
Alcohol and drug abuse 67% 93% 73% 91% 
Depression 84% 86% 47% 97% 
No mental illness 92% 77% 97% 45% 
Anxiety 100% 71% 11% 100% 
Bipolar disorder (mania) 63% 95% 74% 91% 
Learning disability 40% 95% 61% 89% 
Personality disorder 43% 94% 46% 94% 
 
Reliability for internal consistency 
In order to assess validity, and, in particular, reliability, Cronbach's Alpha was calculated. 
Reliability was considered as excellent if alpha was greater than 0.9; good with values 
between 0.7 and 0.9, acceptable with values between 0.6 and 0.7, poor with values between 
0.5 and 0.6, and unacceptable when it was less than 0.5.  
Table 3 shows Cronbach's Alpha for every subscale (Symptoms). The internal consistency 
for depression, mania and disorientation was good with alpha values greater than 0.7. The 
lower value was for memory with poor internal consistency. 
Table 3. Reliability for internal consistency. 
Symptoms Cronbach’s alpha 
Anxiety 0.68 
Depression 0.70 










None of the participants declined participation in the study, and none gave any negative 
feedback. When asked what they thought of the interview, most expressed satisfaction that 
the GPs covered all aspects of their mental health using the GMHAT/PC. The GPs who 
interviewed patients found the GMHAT/PC user friendly and asked whether they could 
continue using it in their routine practice. 
Discussion: 
The GMHAT/PC shows good agreement with psychiatrist diagnosis for any mental 
disorder. The tool has better agreements for the diagnosis of psychosis, depression, bipolar 
(mania) and alcohol and drug abuse. The agreement was excellent for the diagnosis of 
organic disorders. It’s important to clarify that Kappa values are affected by the prevalence 
of the diagnosis (Viera & Garrett, 2005). That could explain the low agreement for anxiety 
disorders because those are the diagnosis with the lowest number of cases (10). 
The results shows that GMHAT/PC have the capacity to correctly identified patients with 
any mental disorder, specifically psychosis, depression and anxiety. In contrast, the 
sensibility for the diagnosis of mania, learning disorders, personality problems and alcohol 
and drug disorders is low. That’s not meant necessarily a problem with the GMHAT. In 
clinical practice is well known that learning disability, personality disorders and substance 
abuse are difficult diagnosis that they are not usually made in one session. Eventually, the 
psychiatrists need to make additional assessments and tests to be sure of the diagnosis. For 
this reason, is not expected that those diagnosis are easily made in a primary care level. 
The GMHAT shows a very good capacity to exclude any diagnosis correctly. This applies 
also with the diagnosis with low sensitivity. High levels of specificity are important 
because demonstrate that the GMHAT is more a diagnostic instrument than a screening 
instrument. Mental Health Gap Action Plan, developed by WHO, recommend as key 
actions the development of simplified diagnostic and treatment tools (WHO, 2008). In 
primary care caution should be used when using screening instruments; scales measuring 
symptomatology tend to have low specificity leading to greater false positives. Therefore, 
screening instruments should be used to alert GPs that further clinical evaluation is 
necessary, but not to determine diagnoses. In the other side, if GPs could have diagnostic 
tools, the evidence suggests that with appropriate training and supervision the primary care 
professionals can deliver a good deal of care (WHO, 2008). 
The proportions of positive diagnosis in the GMHAT that are true positive diagnosis are 
high for any mental illness, especially psychosis, organic disorders and alcohol and drug 
abuse.  
The negative predicted value was very high for all diagnosis, confirming GMHAT 
diagnosis properties.  
The GMHAT identify fewer patients with alcohol and drug problems than the psychiatrists. 
All patients were asked about substance use, that means some patients deny its use and the 
GP couldn’t register the information in the tool. 
GPs identify more cases of psychosis than the psychiatrists. Some of these patients have 
behavioral disorders associated to drug abuse. It could be challenging for the GP to 
differentiate between dysfunctional and impulsive attitudes and psychosis. The same 
happen with patients with borderline personality, antisocial behavior and impulse control 
disorders. GPs also diagnose psychosis in patients who really have maniac symptoms 
instead. 
Some patients with psychiatrists’ diagnosis of depression were identified by the GMHAT 
as anxiety. That’s not properly a mistake. In primary care the most common co-occurrence 
is depression and anxiety (Sartorius, Ustün, Lecrubier, & Wittchen, 1996). The results of 
this study also demonstrate that depression score showed a significant correlation with 
anxiety scores. That could imply that most of the patients with depression diagnosis really 
have a mix anxiety-depression disorder.  
GMHAT identify depression in patients with psychiatrist’s diagnosis of personality 
disorder, specifically borderline. It could be estimated that 20% to 50% of inpatients and 
50% to 85% of out-patients with a current major depressive disorder have an associated 
personality disorder (Corruble, Ginestet, & Guelfi, 1996). Cluster B personality disorders, 
in particular borderline (10–30%), seem to be overrepresented (Corruble et al., 1996). The 
coexistence of personality disorder and major depression is frequent, and most of the 
patients of this study could have both.  
The GMHAT identify depression in patients with psychiatrists’ diagnosis of alcohol abuse. 
Depressive symptoms are wide spread in alcohol abusing patients of all ages and are much 
more common than diagnosable depressive disorder (Khalid, Kunwar, Rajbhandari, 
Sharma, & Regmi, 2000). The prevalence of major depression in alcohol dependence is 
17%) and there is no significant correlation between severity of alcohol dependence 
(Khalid et al., 2000). 
Some researchers have indicated that mental disorders exist across all cultures and nations 
while recognizing that cultural differences exist in symptom presentation and prevalence 
estimates (Ballenger et al., 2001). Others have suggested the possibility that assessment 
tools like CIDI and other screening instruments and methods do not capture fully accurate 
endorsement of the disorders studied because of language or cultural differences in the 
conceptualization of various symptoms (Asnaani, Richey, Dimaite, Hinton, & Hofmann, 
2010). Differences in meaning of worded prompts or biases towards diagnosis of other 
psychopathology resulted in a decreased validity and reliability of measures that had been 
previously validated in English samples (Asnaani et al., 2010). This point out the 
importance of examining mental health assessment with Spanish validated tools. Is 
important to remark the fact that Spanish is the lenguage from many different countries and 
regions and there are also idiosyncratic differences in language between these groups. 
These types of idiosyncratic differences in language can impact assessment results when 
the test items include words that vary by country or region (Benuto, 2013). For that 
reasons, in this study the GMHAT was translated having several Spanish speaking 
professionals from different countries. 
Spanish is one of the most widely spoken languages in the world; it is the official language 
of 21 countries and the second language in the United States. Therefore, it is relevant to 
have a valid Spanish version of the most used clinical interviews and assessment tools 
(Benuto, 2013). It’s important to notice that an accurate translation does not guarantee 
equivalence between the original and the cross-culturally adapted versions, nor does it 
assure the instrument reliability or validity (Benuto, 2013). That’s why this study is 
relevant because include the translation of the GMHAT but also the reliability, feasibility 
and validity of the Spanish version. 
A good sample size and subjects is the main strength of this study. Previous GMHAT 
studies used samples of 50 to 215 patients; this study interviewed 299 patients. This study 
used consultant psychiatrists’ diagnoses as a gold standard rather than other measurement 
or diagnostic tools, trying to keep the GMHAT/PC assessment as close to routine clinical 
practice as possible. Consultant psychiatrists and professionals doing the assessment in the 
study were blind to each other’s diagnoses. The GP's had no knowledge of the patients 
before the assessment. 
The relatively small number of subjects with some disorders (hypochondriasis, eating 
disorders) in this study could limit the analysis for this group of disorders. 
 
The vast majority of interviews were carried out in mental health units. That implies a 
greater number of diagnoses of psychosis and bipolar and less cases of anxiety and 
depression. It’s important to use the GMHAT/PC Spanish version in primary care level 
where the prevalence of cases is different than in a hospital setting. 
The results of this study confirm its value in clinical uses of this tool. As mentioned in the 
previous sections, the advantage of GMHT/PC over other instruments used in primary care 
is its ability to provide clinically relevant diagnosis. This allows the physician to take 
immediate action to solve the patient’s problem as far as possible without having to refer 
the patient to a specialist. In countries like Colombia, the waiting time to see a specialist is 
between one or three months. Using information technology will let GMHAT/PC based 
assessments to take place more easily in community settings thus improving patient 
experience. This could also reduce travel for patients who lives in rural areas and don’t 
have much incomes to cover travel costs.  
 
The GMHAT could demonstrate that frontline workers can be incorporated successfully 
into an adequate case-detection system that is community and population based and that 
workers can be integrated meaningfully into the pathway to care of patients living in low 
resourced settings. An epidemiological study of psychiatric disorders in rural population 
shows that GMHAT can be used as a standardized diagnosing tool in primary health care 
centers helping the primary care workers to diagnose psychiatric cases in a short span of 
time and also in referring them to specialty centers (personal communication). 
 
One relevant use of a computer assisted tool like the GMHAT may be to implement a 
telepsychiatry model, such as those implemented in countries where limited health care 
infrastructure exists (Thara & Sujit, 2013). Applying this to remote settings with no 
psychiatrists may contribute to prudent gains in reducing stigma by providing treatment at 
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